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accuracy. The end-to-end test procedure requires on average 
70 min preparation time, 30 min at the linear accelerator, 20 
min analysis and administration. It allows end-to-end testing 
to be performed more frequently to assure the accuracy over 
time.  
 
Conclusion: The developed end-to-end test is quick, cost-
effective and easy to implement clinically. It allows to 
frequently highlight geometrical inaccuracies in an image-
guided radiation therapy environment.  
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Purpose or Objective: The Global Harmonisation Group was 
created in 2009 to harmonise and improve the quality 
assurance (QA) of radiation therapy implemented worldwide 
in multi-institutional clinical trials. The aim is to achieve a 
consistent platform to provide and share QA processes in 
clinical trials such that the workload for both the institutions 
and the QA groups is reduced and streamlined. As part of this 
aim, the group reviewed their reporting techniques to better 
understand each other’s approaches and agree on core 
information which would be included as part of future 
creation of a standard template. This could potentially lead 
to the ability to use each other’s reports in lieu of 
unnecessary duplication 
 
Material and Methods: A survey was created to find a list of 
core information which could be included in future dosimetry 
credentialing reports. Answers were requested to give 
opinion from each group as to what should be included as a 
minimum in these reports. Some QA groups use site visits or 
postal phantoms, whereas some use a virtual phantom (i.e. 
local QA measurement) and others use both. The questions 
were divided to allow responses for both types. Questions 
were circulated amongst the groups beforehand and all 
comments and contributions were incorporated. 
 
Results: All seven current member groups replied. Results 
were divided into three categories, 1)information which all 
groups agreed should be included 2)information which the 
majority use and the others often use which could be 
discussed as being agreed on inclusion and 3)information 
which was not used by all groups, but which could be used by 
those who did (see table 1). 
 
Table 1 Agreed information in clinical trial QA group reports 
 
Conclusion: The survey showed that that there is a wide 
variation in the information currently provided in the reports 
from the various QA organisations, which may hamper their 
mutual acceptance. Following discussion there were several 
pieces of information which were agreed should always be 
included and these constitute the beginning of an agreed list 
of included core information. There are several more pieces 
of information which the majority always include and the 
others use often or sometimes. These could be discussed to 
understand when and why they are not used and perhaps 
considered for inclusion. There are some others where not all 
members use the information because they do not use a 
gamma index analysis, however these could be included for 
those who do use the gamma index. There is also some 
information which sometimes included, but which is always 
included when needed. These cases will be discussed and 
decided if these should be included in specific cases, perhaps 
including a flowchart to aid standardisation. Some groups 
have already reviewed or are in the process of reviewing 
their reports to ensure inclusion of core information. 
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Purpose or Objective: To present an overview and the 
current status of Novalis Certification, which provides a 
comprehensive and independent assessment of safety and 
quality in stereotactic radiosurgery (SRS) and stereotactic 
body radiation therapy (SBRT), ensuring the highest standards 
and consistency of practice. 
 
Material and Methods: The Novalis Certification program 
includes a review of SRS/SBRT program structure, adequacy 
of personnel resources and training, appropriateness and use 
of technology, program quality management, patient-specific 
quality assurance and equipment quality control. Currently 
ten auditors support the program, with six in North America, 
three in Europe and one in Asia, each bringing a minimum of 
a decade of experience in stereotactic practice. Centres 
applying for Novalis Certification complete a self-study 30 
days prior to a scheduled one-day site visit by one to two 
reviewers. Reviewers generate a descriptive 77-point report 
which is reviewed and voted on by a multidisciplinary expert 
panel of 3 medical physicists, 2 radiation oncologists and 2 
neurosurgeons. Outcomes of reviews may include mandatory 
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requirements and optional recommendations, with the 
former requiring resolution prior to award of Certification. 
 
Results: To date, 14 institutions have received Novalis 
Certification, including 6 in Europe, 3 in North America, 4 in 
Australia and 1 in Asia. An additional 90 certification 
applications are pending; approximately one half and one 
third of these are sites are in Europe and North America, 
respectively. Nine of the 14 reviews have resulted in 
mandatory requirements, however all of these were 
addressed within three months of the audit report. Individual 
reviews have produced from 2 to 9 specific recommendations 
ranging from programmatic to technical in nature. 
 
Conclusion: Novalis Certification is a unique and active peer 
review program assessing safety and quality in SRS and SBRT, 
while recognizing high calibre of practice internationally. The 
standards-based approach is capable of highlighting 
outstanding requirements and providing recommendations to 
enhance both new and established programs. 
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Purpose or Objective: Log files contain information about 
Varian accelerators deliveries of dynamic treatments. This 
information includes actual and expected leaf positions 
throughout the treatment. Log files have been proposed by 
several authors to evaluate leaf position errors. In this study, 
log files of Clinac (dynalogs) and Truebeam (trajectory log 
files) accelerators have been analyzed to compare leaf 
positioning errors of dynamic treatments in different 
generations of clinical linear accelerators. 
 
Material and Methods: More than 30000 log files have been 
analyzed, coming from four Clinac accelerators (one Trilogy, 
two Clinac 21EX, one Clinac 2100CD equipped with 
Millennium 120MLC) and one Truebeam accelerator 
(Truebeam STx 2.0 equipped with HD 120 MLC) of three 
different institutions. Analyzed Truebeam log files 
correspond to VMAT and dIMRT treatments whereas Clinac log 
files only correspond to dIMRT treatments.  
Clinac accelerators control system has approximately a 50ms 
delay (one control cycle time). At each control cycle, MLC 
controller compares the planned to the actual positions. But 
in this comparison, the actual position is delayed 50 ms from 
the planned one. This effect causes that measured positions 
appear in dynalogs one cycle out of phase with respect to the 
planned positions. Therefore, error statistics present an error 
component proportional to leaf speed. A recent research of 
our group has studied this effect and, as a result, we have 
proposed to calculate error statistics without time delay 
effect to evaluate the MLC positioning deviations. In 
Truebeam accelerators this effect does not exist due to the 
proactive design of the MLC control system.  
Leaf positioning RMS errors and 95th percentile errors were 
calculated to evaluate MLC performance with and without 
time delay effect. Log files were analyzed using an in-house 
Matlab program. 
 
Results: In Clinac accelerators, the mean RMS error was 0.35, 
0.34, 0.33 and 0.29 mm for each linac. The mean 95th 
percentile error was 0.62, 0.61, 0.62 and 0.58 mm. Without 
time delay effect, the mean RMS error was0.038, 0.042, 
0.040 and 0.026 mm for each linac. The mean 95th percentile 
error was 0.054, 0.057, 0.057 and 0.046 mm.  
In Truebeam accelerator, the mean RMS error and the mean 
95th percentile for VMAT treatments were 0.038 mm and 
0.07 mm. For IMRT treatments, the mean RMS error and the 
mean 95th percentile were 0.027 mm and 0.052 mm. 
 
Conclusion: Truebeam MLC positioning errors are 
substantially lower than those of Clinac machine models, 
mainly due to the proactive design of Truebeam control 
system. However error statistics without time delay effect in 
Clinac machines, have the same order of magnitude of 
Truebeam ones. 
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Purpose or Objective: As the number of stereotactic 
radiotherapy applications is increasing and image guided 
techniques are superseding frame based solutions in cranial 
as well as in extracranial stereotactic applications the need 
to include imaging and positioning devices in the regular 
quality management is obvious. A very common test to check 
the deviation between the radiation isocentre and the room 
lasers is the Winston-Lutz test. However, this test lacks 
significance in combination with image guided stereotactic 
treatment since the patient is positioned by the image 
guidance devices rather than by the room lasers. The purpose 
of this project was, to implement a practical workflow to 
assess the isocentre and positioning accuracy of image guided 
stereotactic applications. 
 
Material and Methods: The concept of our approach is based 
on the Winston-Lutz test except that positioning is done 
automatically by the image guidance devices rather than by 
the room lasers. Therefore a pelvis phantom including a 
metal sphere is roughly positioned on the treatment couch. 
By the use of an image guidance device (e.g. CBCT, non-
coplanar imaging) translational and rotational correction 
values are acquired and sent to a 6-DOF robotic couch. After 
the phantoms position is adjusted by movements of the 
robotic couch, the metal sphere inside the phantom should 
be positioned exactly at the radiation isocentre of the linear 
accelerator. The result of the image guided positioning is 
recorded by portal images. For this purpose a small radiation 
field (2x2 cm²) is applied from up to 8 different gantry 
angles. Afterwards the radiation field isocentre, the 
isocentre position of the metal sphere as well as the 
deviation is calculated by a software that was developed in-
house. 
 
Results: This end-to-end test provides quantitative 
information on the achievable positioning accuracy of an 
image guided stereotactic application in the clinical 
situation. Besides, the deviations of the radiation isocentre 
from the mechanical isocentres of the gantry, collimator and 
couch can be analyzed using the same setup. The test is not 
restricted to a specific image guidance modality. 
 
Conclusion: A regular assessment of all systems included in 
stereotactic patient positioning is highly recommended. Due 
to the short execution time this test is suitable for regular 
assessments in the QA routine. 
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Purpose or Objective: The physician review of the treatment 
plan upon completion by the treatment planner is a critical 
clinical process, since it is during this exchange where the 
physician verifies and confirms the treatment intent. Several 
near misses in our practice raised the awareness of our group 
regarding the quality and safety of this process. Moreover, 
there was no standardization of the review process and no 
additional safety barrier to detect if the prescription defined 
by the physician matches the treatment intend. Our goal is to 
use a safety checklist to improve the quality and safety as 
